Publications by authors named "Anand Prakash Singh"

Claim this Profile
E
Environmental Pollutants as Emerging Concerns for Cardiac Diseases: A Review on Their Impacts on Cardiac Health.
Vinay Kumar, Hemavathy S, Lohith Kumar Dasarahally Huligowda, Mridul Umesh, Pritha Chakraborty, Anand Prakash Singh

Biomedicines· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The machine learning and geostatistical approach for assessment of arsenic contamination levels using physicochemical properties of water.
Arghya Chattopadhyay, Anand Prakash Singh, Siddharth Kumar, Jayadeep Pati, Amitava Rakshit

Water Sci Technol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system.
Vijay Kumar, Anand Prakash Singh, Nicholas Wheeler, Cristi L Galindo, Jong-Joo Kim

Expert Opin Drug Saf· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Phosphorus Application on Arsenic Species Accumulation and Co-Deposition of Polyphenols in Rice Grain: Phyto and Food Safety Evaluation.
Arghya Chattopadhyay, Anand Prakash Singh, Deepak Kasote, Indrajit Sen, Ahmed Regina

Plants (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteotoxicity: A Fatal Consequence of Environmental Pollutants-Induced Impairments in Protein Clearance Machinery.
Shweta Devi, Jong-Joo Kim, Anand Prakash Singh, Surendra Kumar, Ashish Kant Dubey, Sandeep Kumar Singh, Ravi Shankar Singh

J Pers Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib.
Anand Prakash Singh, Prachi Umbarkar, Sultan Tousif, Hind Lal

Int J Cardiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy.
Frank J Raucci, Anand Prakash Singh, Jonathan Soslow, Larry W Markham, Lin Zhong

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation.
Anand Prakash Singh, Sultan Tousif, Prachi Umbarkar, Hind Lal

J Clin Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity.
Manisha Gupte, Prachi Umbarkar, Anand Prakash Singh, Qinkun Zhang, Sultan Tousif

Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial variability of arsenic in Indo-Gangetic basin of Varanasi and its cancer risk assessment.
Arghya Chattopadhyay, Anand Prakash Singh, Satish Kumar Singh, Arijit Barman, Abhik Patra

Chemosphere· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regeneration.
Anand Prakash Singh, Prachi Umbarkar, Yuanjun Guo, Thomas Force, Manisha Gupte

Cardiovasc Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
Manisha Gupte, Samvruta Tumuluru, Jennifer Y Sui, Anand Prakash Singh, Prachi Umbarkar

Int J Cardiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
Anand Prakash Singh, Swati Sharma, Kirti Pagarware, Rafay Anwar Siraji, Imran Ansari

Sci Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.
Yuanjun Guo, Manisha Gupte, Prachi Umbarkar, Anand Prakash Singh, Jennifer Y Sui

J Mol Cell Cardiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.
Anand Prakash Singh, Saima Aijaz

Bioengineered· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enteropathogenic E. coli: breaking the intestinal tight junction barrier.
Anand Prakash Singh, Saima Aijaz

F1000Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gp63 based vaccine candidate against Visceral Leishmaniasis.
Sukrat Sinha, Shanthy Sundaram, Anand Prakash Singh, Ashutosh Tripathi

Bioinformation· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis